Cargando…

CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada

INTRODUCTION: Despite the availability of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART), 21 793 people were newly diagnosed with HIV in Europe in 2019. The Concerted action on seroconversion to AIDS and death in Europe study aims to understand current drivers of the HIV epidemic;...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Burga, Elisa, Tariq, Shema, Touloumi, Giota, Gill, John, Nicholls, Emily Jay, Sabin, Caroline, Mussini, Cristina, Meyer, Laurence, Volny Anne, Alain, Carlander, Christina, Grabar, Sophie, Jarrin, Inma, Van der Valk, Marc, Wittkop, Linda, Spire, Bruno, Pantazis, Nikos, Burns, Fiona M, Porter, Kholoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186449/
https://www.ncbi.nlm.nih.gov/pubmed/37169505
http://dx.doi.org/10.1136/bmjopen-2022-070837
_version_ 1785042560574554112
author Ruiz-Burga, Elisa
Tariq, Shema
Touloumi, Giota
Gill, John
Nicholls, Emily Jay
Sabin, Caroline
Mussini, Cristina
Meyer, Laurence
Volny Anne, Alain
Carlander, Christina
Grabar, Sophie
Jarrin, Inma
Van der Valk, Marc
Wittkop, Linda
Spire, Bruno
Pantazis, Nikos
Burns, Fiona M
Porter, Kholoud
author_facet Ruiz-Burga, Elisa
Tariq, Shema
Touloumi, Giota
Gill, John
Nicholls, Emily Jay
Sabin, Caroline
Mussini, Cristina
Meyer, Laurence
Volny Anne, Alain
Carlander, Christina
Grabar, Sophie
Jarrin, Inma
Van der Valk, Marc
Wittkop, Linda
Spire, Bruno
Pantazis, Nikos
Burns, Fiona M
Porter, Kholoud
author_sort Ruiz-Burga, Elisa
collection PubMed
description INTRODUCTION: Despite the availability of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART), 21 793 people were newly diagnosed with HIV in Europe in 2019. The Concerted action on seroconversion to AIDS and death in Europe study aims to understand current drivers of the HIV epidemic; factors associated with access to, and uptake of prevention methods and ART initiation; and the experiences, needs and outcomes of people with recently acquired HIV. METHODS AND ANALYSIS: This longitudinal observational study is recruiting participants aged ≥16 years with documented laboratory evidence of HIV seroconversion from clinics in Canada and six European countries. We will analyse data from medical records, self-administered questionnaires, semistructured interviews and participatory photography. We will assess temporal trends in transmitted drug resistance and viral subtype and examine outcomes following early ART initiation. We will investigate patient-reported outcomes, well-being, and experiences of, knowledge of, and attitudes to HIV preventions, including PrEP. We will analyse qualitative data thematically and triangulate quantitative and qualitative findings. As patient public involvement is central to this work, we have convened a community advisory board (CAB) comprising people living with HIV. ETHICS AND DISSEMINATION: All respective research ethics committees have approval for data to contribute to international collaborations. Written informed consent is required to take part. A dissemination strategy will be developed in collaboration with CAB and the scientific committee. It will include peer-reviewed publications, conference presentations and accessible summaries of findings on the study’s website, social media and via community organisations.
format Online
Article
Text
id pubmed-10186449
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-101864492023-05-17 CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada Ruiz-Burga, Elisa Tariq, Shema Touloumi, Giota Gill, John Nicholls, Emily Jay Sabin, Caroline Mussini, Cristina Meyer, Laurence Volny Anne, Alain Carlander, Christina Grabar, Sophie Jarrin, Inma Van der Valk, Marc Wittkop, Linda Spire, Bruno Pantazis, Nikos Burns, Fiona M Porter, Kholoud BMJ Open HIV/AIDS INTRODUCTION: Despite the availability of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART), 21 793 people were newly diagnosed with HIV in Europe in 2019. The Concerted action on seroconversion to AIDS and death in Europe study aims to understand current drivers of the HIV epidemic; factors associated with access to, and uptake of prevention methods and ART initiation; and the experiences, needs and outcomes of people with recently acquired HIV. METHODS AND ANALYSIS: This longitudinal observational study is recruiting participants aged ≥16 years with documented laboratory evidence of HIV seroconversion from clinics in Canada and six European countries. We will analyse data from medical records, self-administered questionnaires, semistructured interviews and participatory photography. We will assess temporal trends in transmitted drug resistance and viral subtype and examine outcomes following early ART initiation. We will investigate patient-reported outcomes, well-being, and experiences of, knowledge of, and attitudes to HIV preventions, including PrEP. We will analyse qualitative data thematically and triangulate quantitative and qualitative findings. As patient public involvement is central to this work, we have convened a community advisory board (CAB) comprising people living with HIV. ETHICS AND DISSEMINATION: All respective research ethics committees have approval for data to contribute to international collaborations. Written informed consent is required to take part. A dissemination strategy will be developed in collaboration with CAB and the scientific committee. It will include peer-reviewed publications, conference presentations and accessible summaries of findings on the study’s website, social media and via community organisations. BMJ Publishing Group 2023-05-11 /pmc/articles/PMC10186449/ /pubmed/37169505 http://dx.doi.org/10.1136/bmjopen-2022-070837 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle HIV/AIDS
Ruiz-Burga, Elisa
Tariq, Shema
Touloumi, Giota
Gill, John
Nicholls, Emily Jay
Sabin, Caroline
Mussini, Cristina
Meyer, Laurence
Volny Anne, Alain
Carlander, Christina
Grabar, Sophie
Jarrin, Inma
Van der Valk, Marc
Wittkop, Linda
Spire, Bruno
Pantazis, Nikos
Burns, Fiona M
Porter, Kholoud
CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada
title CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada
title_full CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada
title_fullStr CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada
title_full_unstemmed CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada
title_short CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada
title_sort cascade protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired hiv infection through a multicentre mixed-methods observational study in europe and canada
topic HIV/AIDS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186449/
https://www.ncbi.nlm.nih.gov/pubmed/37169505
http://dx.doi.org/10.1136/bmjopen-2022-070837
work_keys_str_mv AT ruizburgaelisa cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT tariqshema cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT touloumigiota cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT gilljohn cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT nichollsemilyjay cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT sabincaroline cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT mussinicristina cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT meyerlaurence cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT volnyannealain cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT carlanderchristina cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT grabarsophie cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT jarrininma cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT vandervalkmarc cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT wittkoplinda cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT spirebruno cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT pantazisnikos cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT burnsfionam cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT porterkholoud cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada
AT cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada